Organogenesis Holdings
ORGO
31 hedge funds and large institutions have $11.8M invested in Organogenesis Holdings in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
91% more capital invested
Capital invested by funds: $6.17M → $11.8M (+$5.63M)
55% more funds holding
Funds holding: 20 → 31 (+11)
0.85% more ownership
Funds ownership: 0.89% → 1.74% (+0.85%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.58M |
| 2 |
State Street
Boston,
Massachusetts
|
+$904K |
| 3 |
MC
Moors & Cabot
Boston,
Massachusetts
|
+$672K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$595K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$370K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$761K |
| 2 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$348K |
| 3 |
Millennium Management
New York
|
-$311K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$202K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$88K |
ORGO Hedge Fund Activity: Q2 2019 in Review
31 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q2 2019, worth a combined $11.8M — up 91% from $6.17M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ORGO positions and 5 closed out — a net gain of 11 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, adding an estimated $3.58M. The largest seller was Goldman Sachs, exiting entirely with an estimated $761K sold.
- 31 institutional investors held Organogenesis Holdings (ORGO) as of Q2 2019, up from 20 in Q1 2019.
- Funds reported $11.8M of Organogenesis Holdings stock for Q2 2019, up 91% quarter-over-quarter.
- 16 funds opened new Organogenesis Holdings positions in Q2 2019 and 5 closed out, a net change of +11 holders.
- The largest Organogenesis Holdings buyer in Q2 2019 was BlackRock, an estimated $3.58M added.
- The largest Organogenesis Holdings seller in Q2 2019 was Goldman Sachs, an estimated $761K sold.
Based on aggregated 13F filings for Q2 2019.